Global view of human protein glycosylation pathways and functions

KT Schjoldager, Y Narimatsu, HJ Joshi… - … reviews Molecular cell …, 2020 - nature.com
Glycosylation is the most abundant and diverse form of post-translational modification of
proteins that is common to all eukaryotic cells. Enzymatic glycosylation of proteins involves a …

Recent developments in bioprocessing of recombinant proteins: expression hosts and process development

NK Tripathi, A Shrivastava - Frontiers in Bioengineering and …, 2019 - frontiersin.org
Infectious diseases, along with cancers, are among the main causes of death among
humans worldwide. The production of therapeutic proteins for treating diseases at large …

An orthogonalized PYR1-based CID module with reprogrammable ligand-binding specificity

SY Park, J Qiu, S Wei, FC Peterson, J Beltrán… - Nature Chemical …, 2024 - nature.com
Plants sense abscisic acid (ABA) using chemical-induced dimerization (CID) modules,
including the receptor PYR1 and HAB1, a phosphatase inhibited by ligand-activated PYR1 …

Genetic glycoengineering in mammalian cells

Y Narimatsu, C Büll, YH Chen, HH Wandall… - Journal of Biological …, 2021 - ASBMB
Advances in nuclease-based gene-editing technologies have enabled precise, stable, and
systematic genetic engineering of glycosylation capacities in mammalian cells, opening up a …

Bioprocess systems analysis, modeling, estimation, and control

Y Luo, V Kurian, BA Ogunnaike - Current Opinion in Chemical Engineering, 2021 - Elsevier
The production of monoclonal antibody (mAb) therapeutics, a rapidly growing multi-billion-
dollar enterprise in the biopharmaceutical industry, faces major challenges in achieving …

Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinoma

RQ Wu, XM Lao, DP Chen, H Qin, M Mu, WJ Cao… - Immunity, 2023 - cell.com
The reinvigoration of anti-tumor T cells in response to immune checkpoint blockade (ICB)
therapy is well established. Whether and how ICB therapy manipulates antibody-mediated …

Precision design of stable genetic circuits carried in highly‐insulated E. coli genomic landing pads

Y Park, A Espah Borujeni, TE Gorochowski… - Molecular systems …, 2020 - embopress.org
Genetic circuits have many applications, from guiding living therapeutics to ordering process
in a bioreactor, but to be useful they have to be genetically stable and not hinder the host …

Glycan-mediated molecular interactions in bacterial pathogenesis

S Lee, S Inzerillo, GY Lee, EM Bosire, SK Mahato… - Trends in …, 2022 - cell.com
Glycans are expressed on the surface of nearly all host and bacterial cells. Not surprisingly,
glycan-mediated molecular interactions play a vital role in bacterial pathogenesis and host …

N-Glycosylation

T Hirata, Y Kizuka - The role of glycosylation in health and disease, 2021 - Springer
N-glycosylation is a highly conserved glycan modification, and more than 7000 proteins are
N-glycosylated in humans. N-glycosylation has many biological functions such as protein …

Artificial intelligence in the analysis of glycosylation data

H Li, AWT Chiang, NE Lewis - Biotechnology advances, 2022 - Elsevier
Glycans are complex, yet ubiquitous across biological systems. They are involved in diverse
essential organismal functions. Aberrant glycosylation may lead to disease development …